Join
Live feed
·
PRReleasevia Quantisnow
Scopus BioPharma Inc. logo

Scopus BioPharma's Subsidiary — Duet BioTherapeutics — Presents Compelling New Data for a Novel Treatment for Malignant Glioma at 38th Annual Meeting of the Society for Immunotherapy of Cancer

ByQuantisnow·Wall Street's wire, on your screen.
SCPS· Scopus BioPharma Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SCPS (Scopus BioPharma Inc.) and more on Quantisnow.